Tongyi Dou
Impact in
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 10%
Papers in
- Pharmacology 12
- Cholinesterase and Neurodegenerative Diseases 10
- Pharmacogenetics and Drug Metabolism 6
- Pharmacological Effects of Natural Compounds 4
- Co-authors
- Guang‐Bo Ge (27 shared papers)Ling Yang (16 shared papers)Ping Wang (12 shared papers)Qiang Jin (7 shared papers)Li‐Wei Zou (9 shared papers)Jie Hou (6 shared papers)Jingnan Cui (3 shared papers)Xia Lv (4 shared papers)
- Journals
- Biotechnology Letters (4 papers)Current Microbiology (2 papers)International Journal of Biological Macromolecules (2 papers)Current Drug Metabolism (2 papers)Enzyme and Microbial Technology (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Tongyi Dou
48 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 117
- Pharmacology 186
- Pharmacology 223
- Biochemistry 77
- Molecular Biology 571
- Spectroscopy 141
Countries citing papers authored by Tongyi Dou
This map shows the geographic impact of Tongyi Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongyi Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongyi Dou more than expected).
Fields of papers citing papers by Tongyi Dou
This network shows the impact of papers produced by Tongyi Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongyi Dou. The network helps show where Tongyi Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Tongyi Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 179 | |
| 2 | 2020 | 72 | |
| 3 | 2017 | 60 | |
| 4 | 2019 | 60 | |
| 5 | 2018 | 58 | |
| 6 | 2018 | 56 | |
| 7 | 2017 | 52 | |
| 8 | 2018 | 46 | |
| 9 | 2017 | 43 | |
| 10 | 2018 | 41 | |
| 11 | 2017 | 40 | |
| 12 | 2018 | 36 | |
| 13 | 2023 | 32 | |
| 14 | 2019 | 29 | |
| 15 | 2017 | 27 | |
| 16 | 2018 | 25 | |
| 17 | 2021 | 25 | |
| 18 | 2019 | 25 | |
| 19 | 2021 | 25 | |
| 20 | 2015 | 23 |
About Tongyi Dou
Tongyi Dou is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Biomedical Engineering and Spectroscopy, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (10 papers), Biofuel production and bioconversion (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Enzyme Production and Characterization (6 papers), Computational Drug Discovery Methods (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Molecular Sensors and Ion Detection (3 papers). The work is most often cited by research in Pharmacology (186 citations), Pharmacology (223 citations), Biochemistry (77 citations), Molecular Biology (571 citations) and Spectroscopy (141 citations). Tongyi Dou has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Guang‐Bo Ge, Ling Yang, Ping Wang, Qiang Jin, Li‐Wei Zou, Jie Hou, Jingnan Cui, Xia Lv, Lei Feng and Zi-Miao Weng. Their work appears in journals such as Biotechnology Letters, Current Microbiology, International Journal of Biological Macromolecules, Current Drug Metabolism and Enzyme and Microbial Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.